Skip to main content
. 2018 Mar 6;10:265–276. doi: 10.2147/CLEP.S158110

Table S1.

The list of potentially nephrotoxic agents we used in sensitivity analysis

Potentially nephrotoxic agents ATC code
Antidepressants/mood stabilizers
Amitriptyline N06AA09
Doxepin Not approved in Japan
Fluoxetine Not approved in Japan
Lithium N05AN01
Antihistamines
Diphenhydramine D04AA32
Doxylamine Not approved in Japan
Antimicrobials
Acyclivir D06BB03
Aminoglycosides J01G
Amphotericin B A01AB04
Beta-lactam J01C, J01D
Foscarnet J05AD01
Ganciclovir J05AB06
Pentamidine P01CX01
Quinolones J01M
Rifanpin J04AB02
Sulfonamides J01EE01
Vancomycin A07AA09
Antiretrovials
Adefovir J05AF08
Cidofovir Not approved in Japan
Tenofovir J05AF07, J05AF13, J05AR03, J05AR09, J05AR17, J05AR18
Indinavir J05AE02
Benzodiazepines N05BA, N05CD, N05CF
Calcineurin inhibitors
Cyclosporine L04AD01
Tacrolimus L04AD02
Cardiovascular agents
Angiotensin-converting enzyme inhibitors C09A, C09B
Angiotensin receptor blockers C09C, C09D
Clopidogrel B01AC04
Ticlopidine B01AC05
Statins C10AA, C10BA
Chemotherapeutics
Carmustine L01AD01
Semustine Not approved in Japan
Cisplatin L01XA01
Interferon-alpha L03AB01, L03AB05, L03AB06, L03AB09, L03AB10, L03AB11, L03AB12, L03AB15
Methotrexate L04AX03
Mitomycin-C L01DC03
Contrast dye V08A
Diuretics
Loops C03CA
Thiazides C03AA
Triamterene C03DB02
Proton pump inhibitors
Lansoprazole A02BC03
Omeprazole A02BC01
Pantoprazole Not approved in Japan
Others
Allopurinol M04AA
Gold therapy M01CB
Haloperidol N05AD01
Pamidronate M05BA03
Phenytoin N03AB02, N03AB52
Quinine P01BC01
Zoledronate M05BA08

Abbreviation: ATC, Anatomical Therapeutic Chemical.